These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1326273)

  • 41. [Immunity of viruses and the effectiveness of vaccines. Mechanism of protective immune response of hosts to viruses].
    Shimizu K
    Nihon Rinsho; 1987 Oct; 45(10):2211-7. PubMed ID: 2452259
    [No Abstract]   [Full Text] [Related]  

  • 42. Enteric viruses exploit the microbiota to promote infection.
    Robinson CM
    Curr Opin Virol; 2019 Aug; 37():58-62. PubMed ID: 31284078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Virus-cell interactions: a classification for virus-caused human disease.
    Robb JA
    Prog Med Virol; 1977; 23():51-61. PubMed ID: 339275
    [No Abstract]   [Full Text] [Related]  

  • 44. [The intestinal microbiota helps shapping the adaptive immune response against viruses].
    Chassaing B
    Med Sci (Paris); 2015 Apr; 31(4):355-7. PubMed ID: 25958747
    [No Abstract]   [Full Text] [Related]  

  • 45. Different aspects of virus persistence (review).
    Barnabishvili N; Topuria T; Gamtsemlidze P; Topuria M
    Georgian Med News; 2012 May; (206):73-8. PubMed ID: 22870843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How specific is too specific? B-cell responses to viral infections reveal the importance of breadth over depth.
    Baumgarth N
    Immunol Rev; 2013 Sep; 255(1):82-94. PubMed ID: 23947349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The meaning of persistent infections in nature.
    Mims CA
    Bull World Health Organ; 1975; 52(4-6):747-51. PubMed ID: 1085228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dynamics of evolutionary competition between budding and lytic viral release strategies.
    Lai X; Zou X
    Math Biosci Eng; 2014 Oct; 11(5):1091-113. PubMed ID: 25347808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Viruses, virulence and pathogenicity.
    Hibbs J; Young NS
    Baillieres Clin Haematol; 1995 Mar; 8(1):1-23. PubMed ID: 7663043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Evasion of mammalian organism defense systems by orthopoxviruses].
    Shchelkunov SN
    Mol Biol (Mosk); 2011; 45(1):30-43. PubMed ID: 21485495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses.
    Kägi D; Hengartner H
    Curr Opin Immunol; 1996 Aug; 8(4):472-7. PubMed ID: 8794015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Viral persistence as a factor in immunity and the pathology of persistence].
    Umanskii KG
    Vestn Akad Med Nauk SSSR; 1977; (5):50-5. PubMed ID: 329607
    [No Abstract]   [Full Text] [Related]  

  • 53. To kill or to cure: options in host defense against viral infection.
    Guidotti LG; Chisari FV
    Curr Opin Immunol; 1996 Aug; 8(4):478-83. PubMed ID: 8794011
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathogenesis of viral infections: the role of the immune response.
    Tinghitella TJ
    Am J Otolaryngol; 1990; 11(5):309-12. PubMed ID: 2264582
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Non-specific resistance to the toxic effects of viruses].
    Pigarevskiĭ VE
    Vopr Virusol; 1972; 17(4):387-94. PubMed ID: 4343849
    [No Abstract]   [Full Text] [Related]  

  • 56. The mounting interest in bacterial and viral pathogenicity.
    Smith H
    Annu Rev Microbiol; 1989; 43():1-22. PubMed ID: 2508538
    [No Abstract]   [Full Text] [Related]  

  • 57. Immunity, viral pathology and assessment of immune dysfunction in virology and toxicology.
    Krakowka S
    Toxicol Pathol; 1987; 15(1):18-26. PubMed ID: 3576074
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Mechanisms of interaction of associative symbionts during viral-bacterial infections].
    Usviatsov BIa; Pan'kov AS; Bukharin OV
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (2):117-21. PubMed ID: 19462521
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunity and immunopathology to viruses: what decides the outcome?
    Rouse BT; Sehrawat S
    Nat Rev Immunol; 2010 Jul; 10(7):514-26. PubMed ID: 20577268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An anamnestic antibody increase in ferrets cross-infected with influenza A2-virus after myxoviruses not belonging to the A-group.
    HARBOE A
    Acta Pathol Microbiol Scand; 1962; 55():425-36. PubMed ID: 13904571
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.